We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£161.61
This is the most expensive it has ever been. Walk away.
£162 today · previous high £162 · all-time low £154
Elsevier Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A (Volume 381) (International Review of Cell and Molecular Biology, Volume 381)
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 63 days · 63 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 63 days • 3 price levels
Price Analysis
Most common price: £155 (33 days, 52.4%)
Price range: £154 - £162
Price levels: 3 different prices over 63 days
Description
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0443161348
- Domain
- Amazon UK
- Release Date
- 23 September 2023
- Listed Since
- 03 February 2023
Barcode
No barcode data available
Similar Products You Might Like
Targeting Signaling Pathways in Solid Tumors Part A: Volume 385 (International Review of Cell and Molecular Biology, Volume 385)
Elsevier
Targeting Signaling Pathways in Solid Tumors Part B (Volume 386) (International Review of Cell and Molecular Biology, Volume 386)
Elsevier
Advanced Cancer Research Protocols Volume 198 - Methods in Cell Biology
Elsevier
Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B: Volume 398 (International Review of Cell and Molecular Biology, Volume 399)
Elsevier
Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A: Volume 391 (International Review of Cell and Molecular Biology, Volume 391)
Elsevier
Epigenetic Regulation of Cancer - Part B: Volume 383 (International Review of Cell and Molecular Biology, Volume 383)
Elsevier
Epigenetic Regulation of Cancer - Part E: Volume 400 (International Review of Cell and Molecular Biology, Volume 400)
Elsevier
Epigenetic Regulation of Cancer - Part D: Volume 390 (International Review of Cell and Molecular Biology, Volume 390)
Elsevier
Epigenetic Regulation of Cancer - Part A (Volume 380) (International Review of Cell and Molecular Biology, Volume 380)
Elsevier
Cancer Cell Biology: Methods and Protocols: 2508 (Methods in Molecular Biology, 2508)
Humana
Advances in Cancer Research (Volume 78)
Elsevier
Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)
Elsevier
Cancer Stem Cells: The Cutting Edge
IntechOpen
The Microbiome in Cancer and Autoimmunity - Part B: Volume 395 (International Review of Cell and Molecular Biology, Volume 395)
Elsevier
Humana Cancer Cell Culture: Methods and Protocols 2645
Humana
The Microbiome in Cancer and Autoimmunity - Part A: Volume 394 (International Review of Cell and Molecular Biology, Volume 394)
Elsevier
Tumor Microenvironment: 180 (Cancer Treatment and Research, 180)
Springer
Tumor Microenvironment and Myelomonocytic Cells
IntechOpen
Facharztwissen Hämatologie Onkologie (MONOGRAPHIE - Fachbuch - Urban & Fischer-Verlag)
Elsevier
Academic Press Cell-based Cancer Immunotherapy Vol 183
Elsevier
Cancer Stem Cells and Signaling Pathways - Academic Press
Elsevier
Advances in Cancer Research (Volume 94)
Elsevier
Viruses as Therapeutic Agents for Cancer: Volume 171 (Advances in Cancer Research, Volume 171)
Elsevier
Influence of Paramyxovirus Infection on DH82 cells: Phenotypical and Functional Characteristics of Canine Histiocytic Sarcoma cells (DH82)
VDM Verlag